Search research articles
Contact Us
Filters
Showing results (41-50 of 167) with videos related to
Page
of 17
Sort By:
The New England Journal of Medicine
|
May 17, 2018
Addressing Generic-Drug Market Failures - The Case for Establishing a Nonprofit Manufacturer
Dan Liljenquist, Ge Bai, Gerard F Anderson
JAMA Internal Medicine
|
February 18, 2020
Charity Care Provision by US Nonprofit Hospitals
Ge Bai, Farah Yehia, Gerard F Anderson
JAMA Network Open
|
November 1, 2022
Anticipating Reforms to the Prescription Drug User Fees Act
Jeromie Ballreich, Mariana Socal, Gerard F Anderson
JAMA Internal Medicine
|
March 19, 2019
Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available
Mariana P Socal, Ge Bai, Gerard F Anderson
Journal of General Internal Medicine
|
September 16, 2020
Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States
Mark K Meiselbach, Ge Bai, Gerard F Anderson
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 31, 2020
Modifying the Criteria for Granting Orphan Drug Market Exclusivity
Mariana P Socal, Sonal Parasrampuria, Gerard F Anderson
Journal of General Internal Medicine
|
November 2, 2021
Correction to: Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States
Mark K Meiselbach, Ge Bai, Gerard F Anderson
Annals of Internal Medicine
|
February 14, 2018
Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing
Ge Bai, Aditi P Sen, Gerard F Anderson
JAMA
|
March 1, 2007
Medicare prescription drug coverage gap: navigating the "doughnut hole" with patients
Scott A Berkowitz, Gary Gerstenblith, Gerard F Anderson
Health Policy (Amsterdam, Netherlands)
|
July 28, 2004
Measuring financial protection in health in the United States
Hugh R Waters, Gerard F Anderson, Jim Mays
Page
of 17
Search research articles
Search
Showing results (41-50 of 167) with videos related to
Sort By:
Page
of 17
The New England Journal of Medicine
|
May 17, 2018
Addressing Generic-Drug Market Failures - The Case for Establishing a Nonprofit Manufacturer
Dan Liljenquist, Ge Bai, Gerard F Anderson
JAMA Internal Medicine
|
February 18, 2020
Charity Care Provision by US Nonprofit Hospitals
Ge Bai, Farah Yehia, Gerard F Anderson
JAMA Network Open
|
November 1, 2022
Anticipating Reforms to the Prescription Drug User Fees Act
Jeromie Ballreich, Mariana Socal, Gerard F Anderson
JAMA Internal Medicine
|
March 19, 2019
Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available
Mariana P Socal, Ge Bai, Gerard F Anderson
Journal of General Internal Medicine
|
September 16, 2020
Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States
Mark K Meiselbach, Ge Bai, Gerard F Anderson
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 31, 2020
Modifying the Criteria for Granting Orphan Drug Market Exclusivity
Mariana P Socal, Sonal Parasrampuria, Gerard F Anderson
Journal of General Internal Medicine
|
November 2, 2021
Correction to: Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States
Mark K Meiselbach, Ge Bai, Gerard F Anderson
Annals of Internal Medicine
|
February 14, 2018
Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing
Ge Bai, Aditi P Sen, Gerard F Anderson
JAMA
|
March 1, 2007
Medicare prescription drug coverage gap: navigating the "doughnut hole" with patients
Scott A Berkowitz, Gary Gerstenblith, Gerard F Anderson
Health Policy (Amsterdam, Netherlands)
|
July 28, 2004
Measuring financial protection in health in the United States
Hugh R Waters, Gerard F Anderson, Jim Mays
Page
of 17